XOMA Royalty (XOMA) FCF Margin (2011 - 2026)

XOMA Royalty (XOMA) reported FCF Margin of 49.69% for Q1 2026, down 526.0% on a YoY basis from 11.66% in Q1 2025, and up 224.27% sequentially from 39.99% in Q4 2025.

XOMA Royalty (XOMA) FCF Margin (2011 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 16 years of FCF Margin data on file, last reported at 49.69% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 526.0% year-over-year to 49.69%; the trailing twelve-month figure through Mar 2026 stood at 20.2% (up 5970.0% YoY), and the FY2025 full-year result was 5.51%, up 21254.0% from the prior year.
  • FCF Margin rose to 49.69% in Q1 2026, from 39.99% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 128.76% in Q2 2025 to a low of 1126.77% in Q1 2023.
  • A 5-year average of 356.99% and a median of 317.62% in 2024 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin plunged 1577865 bps in 2022 and surged 81305 bps in 2024, its largest moves.
  • Tracing XOMA's FCF Margin over 5 years: stood at 457.65% in 2022, then soared by 34 bps to 302.08% in 2023, then sank by 92 bps to 581.2% in 2024, then jumped by 93 bps to 39.99% in 2025, then surged by 224 bps to 49.69% in 2026.
  • Business Quant data shows XOMA's FCF Margin at 49.69% in Q1 2026, 39.99% in Q4 2025, and 128.76% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 49.69%

Historic Data

Download Data
DateValue
Mar 31, 2026 49.69%
Dec 31, 2025 -39.99%
Jun 30, 2025 128.76%
Mar 31, 2025 54.95%
Dec 31, 2024 -581.20%
Sep 30, 2024 -119.84%
Jun 30, 2024 54.27%
Mar 31, 2024 -333.15%
Dec 31, 2023 -302.08%
Sep 30, 2023 -932.89%
Jun 30, 2023 -434.74%
Mar 31, 2023 -1,126.77%
Dec 31, 2022 -457.65%
Sep 30, 2022 -812.20%
Jun 30, 2022 -822.29%
Mar 31, 2022 -36.69%
Dec 31, 2021 15,321.00%
Sep 30, 2021 -559.09%
Jun 30, 2021 -441.18%
Mar 31, 2021 -243.73%